Oncolinx is developing the next generation of antibody-drug conjugates (ADCs)--powerful, targeted cancer therapies that are more effective and have dramatically fewer side effects than current methods of cancer treatment. These therapies can be targeted to nearly any type of cancer and are rapidly becoming the state-of-the-art in cancer treatment. Drawing on the scientific innovation of the National Cancer Institute, the world's leading biotechs and life sciences companies, Oncolinx is redefining the paradigm of cancer therapy.
Company Details
- Employees
- 2
- Founded
- 2013
- Address
- Manager Jobs
- Phone
- +44 2035141013
- co****@****inx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- oncolinx.com
- Keywords
- Jersey City.
Oncolinx Questions
Oncolinx's helpline number is +44 2035141013
Oncolinx's website is oncolinx.com
Oncolinx's LinkedIn profile is https://www.linkedin.com/company/oncolinx
Oncolinx has
2 employees.
View email and phone details for 2
employees at Oncolinx.
Oncolinx's industry is
Biotechnology Research
Oncolinx's top competitors are
Innovel Llc,
Eastdil Secured,
Barclays Investment Bank,
Westcore,
Atlantic Council,
Celularity Inc.,
Longevity Vision,
Freenome,
Stockdale Capital Partners Llc,
Fortress Investment Group.
Oncolinx's support email address is contact@oncolinx.com
Oncolinx's categories are Biotechnology Research
Oncolinx's founding year is 2013
